T

TOLREMO therapeutics AG

14 employees

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Cancer Drug Resistance
High-Throughput Screening
Drug Development
Pharmaceutical
Drug Discovery

Date founded

2017

Funding rounds raised

Total raised

$9.4M

from 5 investors over 5 rounds

T

TOLREMO therapeutics AG raised $3.8M on September 20, 2023

Investors: BioMedPartners

T

TOLREMO therapeutics AG raised $5M on June 10, 2020

Investors: BioMedPartners and Altos Ventures

T

TOLREMO therapeutics AG raised $9.4M on September 24, 2018

Investors: Zürcher Kantonalbank and BioMedPartners

FAQ